Table 2.

Other biological medications.

Medication	Action mechanism	Half-life	Indication (package insert)	Presentation	Dosage
Omalizumab	Anti-IgE	26 days	CSU, allergic asthma	Ampoule-vial with lyophilized powder 100 mg	300 mg SC every 4 weeks
Dupilumab	Anti-IL-4, IL-13	7 days	Moderate to severe AD	Pre-filled syringe, 300 mg	I: 600 mg SC, without 0
					M: 300 mg SC, every 2 weeks
Rituximab	Anti- B Lymphocytes	3 weeks	Moderate to severe PV, RA, Leukemia, Lymphomas, Vasculitis	Ampoule-vial with lyophilized powder 100 mg/10 mL or 500 mg/50 m L	2 doses of 1000 mg with a 14-day intervala

^aDose recommended for RA.